Role of Angiopoietin-like 4 on Bone Vascularization in Chickens Exposed to High-altitude Hypoxia

• Published in: Journal of comparative pathology 2018-05, Vol.161, p.25-33
• Main Authors: Huang, S., Wang, M., Rehman, M.U., Zhang, L., Tong, X., Shen, Y., Li, J.
• Format: Article
• Language: English
• Subjects: Altitude Sickness - metabolism; Angiopoietin-like 4 Protein - metabolism; ANGPTL4; Animals; bone vascularization; chicken; Chickens; Growth Plate - blood supply; high-altitude hypoxia; Neovascularization, Physiologic - physiology; Poultry Diseases - metabolism; Poultry Diseases - pathology; Tibia - blood supply; Tibia - metabolism
• ISSN: 0021-9975; 1532-3129
• DOI: 10.1016/j.jcpa.2018.04.007

The aim of this study was to investigate the role and expression of a novel angiogenic factor (angiopoietin-like 4, ANGPTL4) in tibial growth plates of broiler chickens exposed to high-altitude hypoxia. One-day-old healthy broiler chickens (n = 120) were transported from lowland to a high-altitude hypoxic region (nearly 3,000 m above sea level) and were reared under hypoxic- (natural lower oxygen content) and normoxic conditions (nearly 21% oxygen content) for 14 days. The effect of hypoxia on angiogenesis in the tibial growth plates and hypoxia-inducible factor (HIF)-1α and ANGPTL4 expressions were determined by histological examination, quantitative reverse transcriptase polymerase chain reaction (qRT–PCR), western blot and enzyme-linked immunosorbent assay (ELISA) techniques. The increase in vascular distribution to the hypertrophic chondrocyte zone of tibial growth plates contributed to promoting growth and development of the tibia under hypoxic conditions, which was highly correlated with the upregulation of ANGPTL4 at both the mRNA and protein levels together with activation of HIF-1α under hypoxic conditions. These findings demonstrate that angiogenic factor ANGPTL4 upregulation is involved in tibial growth plate angiogenesis to promote the development of the tibia in broiler chickens under hypoxic conditions. They also suggest that ANGPTL4 may serve as a new molecular therapeutic target for ameliorating tibial dyschondroplasia chicken bone vascularization.